Retinoids (Tretinoin)
FDA Approved
Contents
Description
Tretinoin is a topical retinoid that promotes skin cell turnover and collagen remodeling. It has been used off-label in the management of perforating dermatoses including reactive perforating collagenosis by normalizing keratinization and reducing transepidermal elimination of collagen. It also has applications in various acquired skin conditions.
Indications & Therapeutic Use
Acne vulgaris, photoaging, reactive perforating collagenosis, keratinization disorders
Global Availability (10 countries)
| Country | Access Route | Regulatory Pathway | Lead Time | Status |
|---|---|---|---|---|
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — |
Buy / Source Retinoids (Tretinoin) — GNH India
133 matching products available through GNH India. Select a product to view details and request a quote on the GNH India website.
ACNELYSE
0.05%x 20gcream
Altreno
.5 mg/glotionUSA
Atralin
.05 g/100ggelUSA
Avitcid
EU
BIACNA TOPICAL GEL
0.025 %gelCANADA
Cordes Vas
EU
Effederm
EU
JAMP TRETINOIN
10 MGcapsuleCANADA
Products and ordering are fulfilled by GNH India. You will be redirected to www.gnhindia.com.
Available Through
This drug is available for procurement through the following fulfilment partner.
Fulfilment Partner
Retinoids (Tretinoin)
| Generic Name | Retinoids (Tretinoin) |
| Brands | 1 brand available |
| Active Ingredient | Tretinoin |
| Drug Class | Acne vulgaris |
| Manufacturer | Various |
| Dosage Forms | Topical cream 0.025%, 0.05%, 0.1%; gel 0.01%, 0.025% |
| Medical Code | D10AD01 |
| Orphan Status | No |
| Cold Chain | Not Required |
| Lead Time | 3 days |
| Reg. Status | FDA Approved |
| Countries | 10 countries |
Authority Signals
Last Verified3/21/2026
Data ConfidenceHigh (AI + Pharmacist)
Source Citations11 Validated Nodes